Newspaper Advertisement in respect of special window for re-lodgement of transfer requests of physical shares and launch of saksham niveshak campaign -action required for unclaimed dividend ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sandu Pharmaceuticals has submitted to BSE copies of newspaper advertisements published on 18 October 2025 in 'Navprabha' (English and Marathi). The first notice informs physical shareholders of a one-time SEBI-mandated special window, open from 7 July 2025 to 6 January 2026, allowing re-lodgement of share transfer requests that were rejected, returned, or unprocessed before the 1 April 2019 deadline; re-lodged shares will be processed only in demat form. The second notice announces the launch of the 'Saksham Niveshak' campaign, a 100-day IEPFA/MCA outreach running from 28 July to 6 November 2025, aimed at helping shareholders update KYC details (bank account, nominee, email, mobile, address) and claim any unpaid or unclaimed dividends before they are transferred to the IEPFA. Shareholders are directed to submit requests/documents to the company's RTA, MUFG Intime India Private Limited (formerly Link Intime), at its Vikhroli (West), Mumbai office.
This is a routine investor-awareness and compliance filing and is unlikely to move the share price. Shareholders holding physical shares with previously rejected transfers, or those with unclaimed dividends or outdated KYC, should act before the 6 January 2026 (transfer window) and 6 November 2025 (Saksham Niveshak) deadlines to avoid loss of entitlements.